The metastatic process can be divided into several steps. First, tumor cells are released from the primary tumor and invade the surrounding tissues, enter the vascular or lymphatic circulation, and transit there. Next, the cells arrest in the capillary bed of a distant organ and extravasate from the circulation to organ parenchyma. Finally, tumor cells grow at apparently selective sites which are distant from the original site. Neovascularization toward and into a tumor is crucial for the delivery of nutrition and oxygen to that tumor, and also functions as the metastatic pathway to distant organs. The invasion by tumor cells and endothelial cells has a similar process involving cell adhesion, motility and the degradation of the extracellular matrix (ECM) and tissues.
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Aminopeptidase N (APN)/CD13 is a Zn (2ϩ)-dependent exopeptidase that is anchored to the plasma membrane by its N-terminal segment and acts as an ectoenzyme. 1) We have reported that APN plays an important role in tumor-cell invasion, degradation of the ECM by tumor cells and tumor metastasis and angiogenesis in vitro and in vivo. [2] [3] [4] [5] Functional studies using tumor invasion assays revealed that APN on the tumor cell surface cleaves certain ECM proteins, including type IV collagen and some components of Matrigel. 3, 4) In addition, transfection of the APN gene into A375 human melanoma (A375) cells significantly enhanced the metastatic potential of tumor cells on their intravenous inoculation into nude mice. 5) Bestatin is an inhibitor of APN and aminopeptidase B. [6] [7] [8] The immunomodulatory properties of bestatin have been examined in both preclinical and clinical studies. [9] [10] [11] [12] [13] [14] The pharmacokinetics and biotransformation of bestatin have also been examined in detail. 15, 16) Bestatin has been shown to augment the humoral and cellular immune responses in experimental animals, [17] [18] [19] [20] and can activate murine macrophages to become cytotoxic against tumor cells in vivo and in vitro, possibly through a T-dependent mechanism.
10,20) Talmadge et al. 21) reported significant therapeutic potential of bestatin against pre-existing experimental and spontaneous metastases when it was orally administered at high doses per animal.
We have shown that Bestatin inhibited tumor cell invasion [2] [3] [4] and the formation of capillary structure by HUVECs in vitro and angiogenesis induced by B16-BL6 in syngeneic mice. 22) We also found that the inhibition of tumor invasion and angiogenesis by bestatin is mainly mediated by inhibition of the degradation of the ECM and basement membrane (BM) by tumor and endothelial cells.
In the present study, we investigated the effects of bestatin derivatives on the invasive activity and motility of tumor and endothelial cells in vitro and capillary formation of endothelial cells in vitro.
MATERIALS AND METHODS
Cells and Cell Culture A375 cells were kindly provided by Dr. I. J. Fidler, M.D. Anderson Cancer Center, Houston, TX. A375 cells were maintained as monolayer cultures in RPMI Medium supplemented with 10% FCS and L-glutamine. HUVECs and the culture medium, Hu-Media EG2, were obtained from Kurabo, Osaka, Japan and maintained according to the manufacturer's instructions. All cultures were kept at 37°C in a humidified atmosphere of 5% CO 2 /95% air.
Agents Bestatin (Ubenimex) and its derivatives were prepared by Nippon Kayaku Co. Ltd., and are shown in Table 1 .
Aminopeptidase Assay Aminopeptidase activity was assayed by measuring the amount of 7-amino-4-methylcoumarin (AMC) liberated from L-alanine 4-methylcoumaryl-7-amide (Ala-MCA, Peptide Institute, Osaka, Japan) after incubation. 4) A375 cells (3ϫ10 4 cells/ 100 ml/well) or HUVECs (1ϫ10 4 cells/100 ml/well) were seeded in a 96-well microplate and incubated at 37°C in a humidified atmosphere of 5% CO 2 . After 12 h of incubation, 0.1 mM of Ala-MCA in the presence or absence of bestatin or its derivatives (200 ml) was added to the wells, and the cells were incubated for a further 30 min and cooled to 0°C for 5 min. The supernatant was separated by centrifugation (500 rpm, 10 min, 4°C), heated at 90°C for 1 min and subjected to fluorometric determination of AMC (excitation, 360 nm; emission, 465 nm). The activity was expressed as pmol/min/3ϫ10 4 or 1ϫ10 4 cells, calculated from the amount of AMC formed by the added A375 cells or HUVECs.
Cell Viability Assay The viability of cells was assessed using a WST-1 Cell Counting kit (Wako Pure Chemical Industries, Osaka, Japan). Briefly, A375 cells or HUVECs were seeded and incubated as for the aminopeptidase assay, and the medium was exchanged for new medium (100 ml) containing the compounds at various concentrations. After 24 h of incubation, the WST-1 solution (10 ml) was added to each well 1 h before the end of the experiment. The absorbance at 450 nm was measured using a microplate reader.
Capillary Formation Assay The assay for capillary formation of HUVECs was performed according to a method reported previously with some modifications. 22) Briefly, 48-well plates were coated with 100 ml of Matrigel per well (10 mg/ml, Collaborative Research Co., Bedford, Massachusetts), which polymerizes after 1 h at 37°C. HUVECs (3ϫ10 4 /well) were seeded into the wells and incubated in the presence or absence of the compounds at 37°C for 4 h. The capillary formation was examined by measuring the length of capillary structures visualized in photographs.
Invasion Assay The invasive activity of A375 cells was assayed using transwell cell culture chambers as described previously. 4) Briefly, the lower surface of polyvinylpyrrolidone-free polycarbonate filters with 8.0 mm pores (Nucleopore, Pleasanton CA, U.S.A.) was precoated with fibronectin (5 mg/filter). Matrigel was applied to the upper surface of the filter (2.5 mg/filter), and dried at room temperature under a hood. These filters were designated Matrigel/Fibronectincoated filters. A375 cells were harvested and resuspended to a final concentration of 1.5ϫ10 6 cells/ml in RPMI1640 Medium containing 0.1% bovine serum albumin (BSA) and 100 nM of bestatin or its derivatives. Cells suspensions (100 ml each) were added to the upper compartment and incubated for 8 h at 37°C in a 5% CO 2 atmosphere. The filters were fixed with methanol and stained with hematoxylin and eosin. The cells on the upper surface of the filter were removed by wiping with cotton swabs. The cells that had invaded various areas of the lower surface were manually counted under a microscope. Each assay was performed in triplicate.
Migration Assay The migration of A375 cells in Fibronectin was assayed similar to the invasive activity. The filters were precoated with Fibronectin on their lower surface and dried at room temperature. The subsequent procedures were the same as those used for the invasion assay. In the assay of the HUVECs, HUVECs were harvested and resuspended to a final concentration of 2ϫ10 5 cells/ml in HuMedia EG2 containing 100 nM of bestatin or one of its derivatives. The cell suspension was added to the upper compartment and incubated for 6 h at 37°C in a 5% CO 2 atmosphere. The subsequent procedures were the same as those used for the invasion assay.
Wound Healing Assay HUVECs (3ϫ10 4 cells/500 ml/ well) were seeded in a 24-well microplate and incubated at 37°C in a humidified atmosphere of 5% CO 2 . After 12 h of incubation, the monolayer of HUVECs was wound on the straight with a 1-10 ml micro-tip and then incubated for 6 h at 37°C in a humidified atmosphere containing 5% CO 2 . Cells were fixed with methanol and stained with hematoxylin and eosin. After the staining, cells were washed with water and air-dried. The distance of cells that had migrated into the cell-free space was measured and used to calculate the relative proportion wounded at time 0. All samples were examined in triplicate.
Statistical Analysis Where applicable, data were analyzed using the analysis of variance (ANOVA) according to Dunn's multiple comparison test. The criterion of significance was established as pϽ0.05.
RESULTS AND DISCUSSION
In the present study, we initially attempted to find bestatin derivatives which exhibit increased inhibitory activity toward APN as compared with bestatin itself. We therefore examined the effect of three derivatives (methyl bestatin, BE15 and BE17) as well as bestatin (Table 1 ) on the proliferation of A375 cells and HUVECs in vitro by conducting a WST assay. Neither the derivatives nor bestatin affected the proliferation of either of the cells at concentrations ranging from 5 to 100 nM (data not shown). Therefore, we used 100 nM of bestatin and its derivatives in the subsequent experiments.
We next examined the inhibitory effect of the derivatives on the aminopeptidase activity in A375 cells and HUVECs. The derivatives evidently inhibited the aminopeptidase activ- 
ity of A375 cells as well as did bestatin (Fig. 1A ). BE15 and BE17 had a significant inhibitory effect on HUVECs (Fig.  1B) . The degradation of BM and ECM by various enzymes such as matrix metalloproteinases (MMPs) and aminopeptidases is known to be required for tumor invasion and tumorinduced angiogenesis. 1, 22) Synthetic inhibitors of MMPs, such as batimastat and marimastat, have shown significant anti-metastatic and anti-angiogenic effects in experimental animal models. 23) In fact, MMI270, a novel synthetic hydroxamate-type MMP inhibitor, inhibited the metastasis of orthotopically implanted LLC cells to the lymph node through regulating the lymphangiogenesis-related properties of lymphatic endothelial cells such as degradation of MMP, invasion and capillary formation. 24) We have also reported that the inhibition of tumor metastasis and angiogenesis was associated with inhibition of APN and the degradation of the BM and ECM by bestatin. 4, 22) Recently, MMP-1 was shown to activate protease-activated receptor-1 (PAR-1) and consequently promote cell motility. 25) As shown in Fig. 2A, BE15 and BE17 inhibited the invasion by A375 cells as effectively as bestatin. Although there was no significant difference in the inhibitory effect on the tumor invasion among these derivatives and bestatin, only BE15 significantly inhibited the migration to the fibronectin-coated substrate (pϽ0.01) as compared with the control. Methyl bestatin and BE17 as well as bestatin did not affect the migration of A375 cells (Fig. 2B) .
We also confirmed the effect of BE15 on the migration of HUVECs in wound healing assays because BE15 selectively affects the migration of A375 cells. Similarly, only BE15 showed significant inhibitory effect on the migration of HUVECs (pϽ0.01), as compared with the other derivatives (Fig.  3) . Furthermore, we investigated inhibitory effects of bestatin and its derivatives on the formation of capillary structures by HUVECs (Fig. 4) . HUVECs were seeded in Matrigel-coated wells and monitored for the formation of capillaries. The addition of bestatin and its derivative led to the formation of poorly branching structures, which were shorter in length and present in lesser amounts than the control. Notably, BE15 had a potent inhibitory effect on capillary formation, compared with bestatin and the other derivatives.
We recently reported that haptotactic and horizontal migrations were inhibited on HUVECs treated with APN small interfering RNA. These results suggested that APN play a direct role in cell motility. 26) However, we could not reveal whether anti-aminopeptidase activity of bestatin derivatives correlated with inhibitory effect on cell motility in present study (Figs. 1-3) .
Future experiments employing the techniques such as introducing siRNA for APN in A375 cells might be useful to prove our results. Furthermore, studies on the correlation between structure activity of bestatin derivatives and its inhibitory effect on cell motility are in progress.
Invasive properties including the invasion of tumor cells into BM and ECM and angiogenesis of endothelial cells are considered to play critical roles in the progression of tumor metastasis. The present study demonstrated that a bestatin derivative with inhibitory effect of APN activity, BE15, down-regulated the degradation of the ECM, cell motility of tumor cells and endothelial cells. Thus, BE15 may be a useful candidate for the development of anti-metastatic and antiangiogenic agents. Vol. 29, No. 4 
